Cargando…

Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study

Detalles Bibliográficos
Autores principales:	Bottiroli, Sara, De Icco, Roberto, Vaghi, Gloria, Pazzi, Stefania, Guaschino, Elena, Allena, Marta, Ghiotto, Natascia, Martinelli, Daniele, Tassorelli, Cristina, Sances, Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564953/ https://www.ncbi.nlm.nih.gov/pubmed/34732140 http://dx.doi.org/10.1186/s10194-021-01342-3

Ejemplares similares

Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
por: Sara, Bottiroli, et al.
Publicado: (2021)

Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
por: De Icco, Roberto, et al.
Publicado: (2022)

The Virtual “Enfacement Illusion” on Pain Perception in Patients Suffering from Chronic Migraine: A Study Protocol for a Randomized Controlled Trial
por: Bottiroli, Sara, et al.
Publicado: (2022)

Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
por: Martinelli, Daniele, et al.
Publicado: (2023)

P008. Alexithymia and chronic migraine with medication overuse: what relationship?
por: Bottiroli, Sara, et al.
Publicado: (2015)

O012. Intra-variability of the characteristics of migraine attacks
por: Viana, Michele, et al.
Publicado: (2015)

Negative Short-Term Outcome of Detoxification Therapy in Chronic Migraine With Medication Overuse Headache: Role for Early Life Traumatic Experiences and Recent Stressful Events
por: Bottiroli, Sara, et al.
Publicado: (2019)

P043. Hyperechogenicity of the periaqueductal gray in chronic migraine and episodic migraine as a potential marker of progressive dysfunction: preliminary results with transcranial sonography
por: Guaschino, Elena, et al.
Publicado: (2015)

O010. Migraine aura symptoms last for more than one hour in more than one quarter of patients: results from a prospective diary-aided study
por: Viana, Michele, et al.
Publicado: (2015)

EHMTI-0111. Intra-variability of migraine attacks features
por: Viana, M, et al.
Publicado: (2014)

Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis
por: Corrado, Michele, et al.
Publicado: (2022)

Social cognition in chronic migraine with medication overuse: a cross-sectional study on different aspects of mentalization and social relationships
por: Bottiroli, Sara, et al.
Publicado: (2023)

EHMTI-0024. The typical duration of migraine aura: a prospective diary-based study
por: Viana, M, et al.
Publicado: (2014)

O011. Patients with “prolonged aura” do not show clinical or demographic differences from the patients with “typical aura”
por: Viana, Michele, et al.
Publicado: (2015)

Cost of Chronic and Episodic Migraine: a pilot study from a tertiary headache centre in northern Italy
por: Berra, E, et al.
Publicado: (2015)

EHMTI-0305. Psychological assessment of patients with chronic refractory headache: a consecutive case series
por: Galli, F, et al.
Publicado: (2014)

Thalamocortical Connectivity in Experimentally-Induced Migraine Attacks: A Pilot Study
por: Martinelli, Daniele, et al.
Publicado: (2021)

Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
por: Greco, Rosaria, et al.
Publicado: (2020)

The “care” protocol: outcome of medication overuse headache in a three year follow-up study
por: Sances, G, et al.
Publicado: (2013)

Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse
por: Bottiroli, Sara, et al.
Publicado: (2018)

High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients
por: Cerami, Chiara, et al.
Publicado: (2021)

EHMTI-0045. The succession of aura and headache: a prospective diary-based study
por: Viana, M, et al.
Publicado: (2014)

EHMTI-0046. The succession of aura symptoms: a prospective diary-based study
por: Viana, M, et al.
Publicado: (2014)

Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks
por: De Icco, Roberto, et al.
Publicado: (2021)

Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
por: Demartini, Chiara, et al.
Publicado: (2023)

Experimentally induced spinal nociceptive sensitization increases with migraine frequency: a single-blind controlled study
por: De Icco, Roberto, et al.
Publicado: (2020)

The “care” protocol: the role of personality in a three-year follow-up study of medication overuse headache
por: Galli, F, et al.
Publicado: (2013)

Gender Differences in the Clinical Presentation of Cluster Headache: A Role for Sexual Hormones?
por: Allena, Marta, et al.
Publicado: (2019)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Personality in Chronic Headache: A Systematic Review with Meta-Analysis
por: Bottiroli, Sara, et al.
Publicado: (2023)

Who cares about migraine? Pathways and hurdles in the European region - access to care III
por: Vaghi, Gloria, et al.
Publicado: (2023)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Meeting patient expectations in migraine treatment: what are the key endpoints?
por: Antonaci, Fabio, et al.
Publicado: (2008)

Assessment and characteristics of Erenumab therapy on migraine management
por: Saeed, Haitham, et al.
Publicado: (2022)

Migraine Treatment Using Erenumab: Can Lead to a Cognitive and Psychological Qualitative Improvement?
por: Torrisi, Michele, et al.
Publicado: (2023)

Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study
por: De Icco, Roberto, et al.
Publicado: (2016)

The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN)
por: Filippi, Massimo, et al.
Publicado: (2023)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India
por: Chowdhury, Debashish, et al.
Publicado: (2022)

Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jsloppms6dtdri9pa3gev6a3m0